Healthtech Startups

Eucalyptus is a global telehealth provider that operates a group of digital healthcare clinics treating complex, chronic conditions and offering preventative care. It focuses on patient-directed treatment and safety across its online medicine services.

6 investors

Even helps individuals compare and choose health insurance policies, offering advisory support from enrollment through claims. It provides plans with add-ons such as personal accident cover, advanced treatment cover, domiciliary expenses, maternity and newborn cover, and AYUSH treatment.

6 investors

Ever/Body operates aesthetics centers offering cosmetic and beauty treatments performed by clinical experts, combining in-center procedures with at-home care plans for individual clients. It focuses on science-based, curated aesthetic treatments delivered through a rigorous provider training program.

6 investors

ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.

6 investors

Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway. Its lead candidate, PIKTOR, is an all-oral combination targeting PI3K-alpha, mTORC1, and mTORC2 for cancers including endometrial and HR+/HER2- breast cancer.

6 investors

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic. Spun out from the University of South Australia and Victoria University, the company is based in Australia.

6 investors

FinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.

6 investors

Fitnescity Health operates a consumer-initiated diagnostics platform connecting people to preventive health testing providers including DEXA scans and VO2 Max assessments. The platform partners with medical institutions and imaging centers to make advanced diagnostic testing accessible and provide personalized health analytics.

6 investors

Florence builds technology for managing and running clinical trials, serving research sites, sponsors, and healthcare institutions in the life sciences industry. Its team focuses on integrating software into clinical operations to improve trial efficiency.

6 investors

Flow Medical develops technology for catheter-directed thrombolysis treatment of pulmonary embolism, aiming to improve precision in lytic medication dosing to reduce readmission rates. The company targets interventional cardiologists and radiologists managing acute PE cases.

6 investors

Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke. The company targets patients with cerebrovascular conditions and is advancing the technology toward regulatory approval and commercial deployment.

6 investors

FOLX is a digital healthcare platform designed for LGBTQIA+ adults, providing inclusive and affirming medical care. The platform addresses gaps in mainstream healthcare for LGBTQIA+ communities by delivering accessible services through a digital-first model.

6 investors

Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.

6 investors

Formus Labs develops software and tools for orthopedic surgery and musculoskeletal care, serving surgeons and clinical practitioners. The company combines research, product development, and regulatory expertise in the medical device and digital health space.

6 investors

Found offers clinically-led, personalized weight care that combines evidence-based medical treatment (including provider-prescribed medications) with support to help members lose weight and improve their health. It serves individuals seeking accessible, judgment-free weight management.

6 investors

Foundation Health offers an AI operating system for pharmacies that automates prior authorizations, refill authorizations, financial assistance enrollment, 340B compliance, and patient communications, along with a white-labeled digital pharmacy front door and a healthcare API. It serves health systems, health plans/insurers, and developers, primarily in the US healthcare and pharmacy market.

6 investors

Gabbi offers a clinically-validated online breast cancer risk assessment and virtual visits with nurse practitioners who create personalized care plans and order tests or imaging. It partners with health systems, employers, and providers to identify at-risk women and route them to early detection and screening.

6 investors

Gifthealth operates a digital platform that connects pharmaceutical manufacturers, prescribers, and patients to streamline prescription fulfillment and medication access nationwide. The company addresses barriers in specialty pharmacy care through an integrated hub model that handles prescription intake, fulfillment, and patient adherence.

6 investors

Glidance makes Glide, an intelligent primary mobility aid for people who are blind or have low vision, using patent-pending Agentic Wayfinding technology to physically guide users around obstacles and describe their surroundings in complex pedestrian environments. The wheeled device with a telescoping handle is positioned as a third option alongside the cane or guide dog.

6 investors

GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs. The company operates in the biotech and drug development space.

6 investors

Granata Bio is a US-based biopharmaceutical company focused on reproductive health and fertility, in-licensing IVF medications used outside the US to develop and commercialize them in North America. Its aim is to expand therapeutic options, lower costs, and increase access to fertility treatment for patients.

6 investors

Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

6 investors

Gravie provides health benefits products for small and midsize businesses, including its flagship Comfort level-funded health plan with zero-cost coverage of common services, as well as traditional copay/HSA plans and ICHRA administration. It serves SMB employers and the brokers who sell to them in the U.S. health insurance market.

6 investors

Grokker offers digital wellness content and resources accessible across devices for individuals seeking to improve their wellbeing. The platform provides high-quality health and wellness programming to users globally.

6 investors